초록 ▼

A drug deactivation system according to some embodiments includes at least one drug-retaining region of a drug delivery device and at least one energy source coupled to the at least one drug-retaining region. The at least one drug-retaining region may be configured to retain a drug. The at least one

A drug deactivation system according to some embodiments includes at least one drug-retaining region of a drug delivery device and at least one energy source coupled to the at least one drug-retaining region. The at least one drug-retaining region may be configured to retain a drug. The at least one energy source may be configured to transmit energy to the drug. The drug is capable of being rendered ineffective in the presence of the transmitted energy.

대표청구항 ▼

1. A drug deactivation system comprising: at least one drug-retaining region of a drug delivery device, wherein the at least one drug-retaining region is configured to retain a drug; andat least one energy source coupled to the at least one drug-retaining region, wherein the at least one energy sour

1. A drug deactivation system comprising: at least one drug-retaining region of a drug delivery device, wherein the at least one drug-retaining region is configured to retain a drug; andat least one energy source coupled to the at least one drug-retaining region, wherein the at least one energy source is configured to transmit energy to the drug and wherein the drug is capable of being rendered ineffective in the presence of the transmitted energy. 2. The drug deactivation system of claim 1, wherein the at least one energy source is configured to transmit at least one type of energy selected from the group consisting of mechanical energy, electrical energy, thermal energy, and electromagnetic radiation. 3. The drug deactivation system of claim 2, wherein the at least one energy source includes an electrode. 4. The drug deactivation system of claim 3, further comprising an absorbing element disposed within the at least one drug-retaining region and electrically connected to the electrode, wherein the absorbing element is configured to absorb at least a portion of the drug retained within the at least one drug-retaining region in the presence of a voltage applied from the electrode. 5. The drug deactivation system of claim 4, wherein the absorbing element comprises activated carbon. 6. The drug deactivation system of claim 2, wherein the at least one energy source includes a heating element. 7. The drug deactivation system of claim 2, wherein the at least one energy source includes a light-emitting element. 8. The drug deactivation system of claim 2, wherein the at least one energy source includes an ultrasonic transducer. 9. A drug delivery device, comprising: a housing;at least one drug-retaining region disposed within the housing;a drug retained within the at least one drug-retaining region; andat least one energy source coupled to the at least one drug-retaining region, wherein the at least one energy source is configured to transmit energy to the drug and wherein the drug is capable of being rendered ineffective in the presence of the transmitted energy. 10. The drug delivery device of claim 9, wherein the at least one energy source is disposed within the housing.